Corporate Governance3 Sept 2026, 12:54 pm
Caplin Point Files FY26 Business Responsibility and Sustainability Report
AI Summary
Caplin Point Laboratories Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26, as per SEBI regulations. The report covers the company and its subsidiaries, Caplin Steriles Limited and Caplin One Labs Limited, focusing on manufacturing and sale of pharmaceuticals, which accounts for 100% of its turnover. The company has obtained limited assurance on its BRSR Core disclosures from M/s Alagar & Associates LLP. The report details corporate identity, operational locations, and business activities.
Key Highlights
- Caplin Point submits FY26 BRSR report as per SEBI norms.
- Report covers consolidated entities, excluding immaterial overseas subsidiaries.
- Pharmaceuticals and finished dose formulation is 100% of turnover.
- Independent assurance obtained for BRSR Core disclosures.
- Details on operations, locations, and corporate information provided.
Price Impact
More from CAPLIPOINT